Avalon Investment & Advisory’s Medtronic MDT Stock Holding History

Avalon Investment & Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$12.9M	Buy	160,295 +133,039	+488%	+$10.8M	0.35%	87
2022 Q4	$2.12M	Sell	27,256 -178,198	-87%	-$14.4M	0.06%	168
2022 Q3	$16.6M	Sell	205,454 -155,936	-43%	-$14M	0.51%	65
2022 Q2	$32.4M	Buy	361,390 +13,892	+4%	+$1.41M	0.91%	41
2022 Q1	$38.6M	Buy	347,498 +241,991	+229%	+$25.6M	0.93%	38
2021 Q4	$10.9M	Buy	+105,507	New	+$12.2M	0.27%	96
2017 Q4	–	Sell	-91,041	Closed	-$7.08M	–	369
2017 Q3	$7.08M	Sell	91,041 -2,223	-2%	-$185K	0.23%	141
2017 Q2	$8.28M	Sell	93,264 -1,735	-2%	-$146K	0.27%	121
2017 Q1	$7.65M	Sell	94,999 -71,142	-43%	-$5.56M	0.26%	119
2016 Q4	$11.8M	Sell	166,141 -15,609	-9%	-$1.23M	0.43%	84
2016 Q3	$15.7M	Sell	181,750 -900	-0.5%	-$78.4K	0.59%	57
2016 Q2	$15.8M	Buy	+182,650	New	+$14.8M	0.61%	61

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Avalon Investment & Advisory's MDT Position: Q1 2023 in Review

Avalon Investment & Advisory increased its Medtronic (MDT) stake by 488% in Q1 2023, buying an estimated $10.8M and bringing the position to 160,295 shares worth $12.9M. The position accounts for 0.35% of the portfolio, ranked #87.

Avalon Investment & Advisory first reported a position in MDT in Q2 2016 and has held it in 12 quarters since. The position peaked at $38.6M in Q1 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

Avalon Investment & Advisory held 160,295 shares of Medtronic worth $12.9M as of Q1 2023.
Avalon Investment & Advisory bought 133,039 Medtronic shares in Q1 2023, an estimated $10.8M.
Medtronic made up 0.35% of Avalon Investment & Advisory's portfolio in Q1 2023, its #87 holding.
Avalon Investment & Advisory first reported a position in Medtronic in Q2 2016 and has held it in 12 quarters since.
Avalon Investment & Advisory's Medtronic position peaked at $38.6M in Q1 2022.
1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.